| pubmed-article:12921807 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12921807 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
| pubmed-article:12921807 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
| pubmed-article:12921807 | lifeskim:mentions | umls-concept:C0001642 | lld:lifeskim |
| pubmed-article:12921807 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:12921807 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:12921807 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12921807 | pubmed:dateCreated | 2003-8-18 | lld:pubmed |
| pubmed-article:12921807 | pubmed:abstractText | The Glycine389 variant of the beta-1 adrenergic receptor (beta1AR) generates markedly less cAMP when stimulated in vitro than the more prevalent Arginine389 variant. | lld:pubmed |
| pubmed-article:12921807 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12921807 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12921807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12921807 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12921807 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12921807 | pubmed:issn | 1388-9842 | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:MERIT-HF... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:GreenwoodDarr... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:BallStephen... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:WhiteHazel... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:BalmforthAnth... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:MaqboolAzharA | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:CuthbertRicha... | lld:pubmed |
| pubmed-article:12921807 | pubmed:author | pubmed-author:HallAlistair... | lld:pubmed |
| pubmed-article:12921807 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12921807 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:12921807 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12921807 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12921807 | pubmed:pagination | 463-8 | lld:pubmed |
| pubmed-article:12921807 | pubmed:dateRevised | 2011-6-8 | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:meshHeading | pubmed-meshheading:12921807... | lld:pubmed |
| pubmed-article:12921807 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12921807 | pubmed:articleTitle | An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study. | lld:pubmed |
| pubmed-article:12921807 | pubmed:affiliation | Institute for Cardiovascular Research, University of Leeds, Leeds, UK. hlwhite@doctors.org.uk | lld:pubmed |
| pubmed-article:12921807 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12921807 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:153 | entrezgene:pubmed | pubmed-article:12921807 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12921807 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12921807 | lld:pubmed |
